Edara Research Foundation

What Edara Research Foundation does

Edara Research Foundation (ERF) is a privately held, GLP-certified preclinical contract research organization (CRO) headquartered in Hyderabad, India, operating from a ~20,000-25,000 sq. ft. AAALAC-compliant facility. Founded in 2015-2016, ERF offers an integrated portfolio of in-vitro and in-vivo preclinical services spanning general toxicology, genotoxicity testing, analytical chemistry, medical device biocompatibility, agrochemical testing, alternatives to animal testing, histopathology, clinical pathology, pharmacology models, bioassays, and microbiology — supported by specialized infrastructure including a Class 100,000 double-barrier vivarium, nose-only inhalation exposure systems supplied by CH Technologies USA, and dedicated AHU design to prevent cross-contamination.

The company serves enterprise sponsors across pharmaceutical, biotechnology, agrochemical, specialty chemical, and medical device industries, with studies conducted under OECD GLP, USFDA GLP, ISO, and AAALAC frameworks enabling data acceptance for global regulatory submissions including USFDA, EPA, CIBRC, and SENASA (Argentina). The revenue model is professional-services / fee-for-service, with project-based contracts covering study design, conduct, evaluation, and reporting; pricing is quote-based and project-specific with no publicly disclosed rate card. GTM is direct enterprise field sales, with the facility open to sponsor on-site engagement during studies.

ERF's competitive positioning rests on its dense regulatory accreditation stack (NGCMA GLP through 2026, AAALAC, CPCSEA, ISO 9001:2015, ISO/IEC 17025:2017, Telangana Drug Control, DTL, SENASA), India-based cost structure with international data acceptance, and specialized inhalation toxicology and 3Rs-aligned alternative testing capabilities. The company is founder/management-led with no disclosed institutional ownership, no funding rounds, and no M&A activity in the source data.

Name

Edara Research Foundation

Legal name

Edara Research Foundation

Website

https://edararesearch.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

Edara Research Foundation is a GLP-certified preclinical contract research organization based in Hyderabad, India, providing in-vitro and in-vivo toxicology, genotoxicity, analytical, medical device, and agrochemical testing services to pharmaceutical, biotechnology, and specialty chemical sponsors.

Ownership category

akta.pro rank

Product category

Preclinical Contract Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

akta.pro secondary industries

Nonclinical Study Management & Regulatory Writing (IND-enabling) (HLAGAFAN), Laboratory Quality & GLP/GCLP Compliance (HLAGAKAK), Method Development & Validation (ICH/USP) (HLAGADAB)

Keywords

• Preclinical contract research
• GLP toxicology services
• In-vivo safety studies
• Regulatory toxicology testing
• Biocompatibility testing

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Others, Marketing or Sales

Revenue model

1. Preclinical Contract Research Services: Fee-for-service contract research providing GLP-compliant toxicology, pharmacology, DMPK, biocompatibility and pharmacopoeia testing to pharmaceutical, biotech, agrochemical and specialty chemical clients. Revenue generated through project-based contracts with study design, conduct, evaluation and reporting services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Edara Research Foundation provides GLP-compliant preclinical contract research services, executing in-vitro and in-vivo toxicology, genotoxicity, analytical chemistry, pharmacology, histopathology, clinical pathology, bioassays, microbiology, biocompatibility, and agrochemical safety studies under international regulatory guidelines (OECD, ICH, USFDA, EPA, ISO 10993). Services are delivered from a 20,000–25,000 sq. ft. AAALAC-accredited facility in Hyderabad, with an independent QA unit, dedicated project management, and rapid turnaround of regulatory-grade study reports.

Product overview

Edara Research Foundation (ERF) is a preclinical contract research organization (CRO) offering integrated GLP-compliant research services for the pharmaceutical, biotech, agrochemical, and specialty chemical industries. The company provides a comprehensive portfolio of testing services organized around General Toxicology (core offering), Genotoxicity Testing, Analytical Services, Medical Device Testing (biocompatibility), Agro Chemical Testing, Alternatives to Animal Testing, Histopathology, Clinical Pathology, Pharmacology Models, Bioassays, and Microbiology. These services are supported by state-of-the-art facilities including Animal (vivarium), Inhalation, Clinical Pathology, Histopathology, Analytical Chemistry, and Archives, all designed to deliver seamless preclinical safety and efficacy investigations in compliance with OECD GLP, ISO, AAALAC, and USFDA GLP guidelines.

Differentiator

Problem solved

Functional benefit

Products and services

• General Toxicology GLP-compliant toxicology studies per OECD, ICH, Schedule Y, and EPA guidelines, including Maximum Tolerable Dose, Dose Range Finding, Single and Repeated Dose Toxicity, and Skin Sensitization Studies, for pharmaceutical and chemical sponsors.
• Genotoxicity Testing In vitro and in vivo genetic toxicology studies including Bacterial Reverse Mutation Test (Ames test), Micronucleus Tests, and Chromosome Aberration Tests, conducted in compliance with OECD and US-EPA guidelines for regulatory submissions.
• Analytical Services Analytical chemistry services including Five Batch Analysis, Method Development & Validation, Dose Formulation Analysis, Shelf Life Studies, Residue Studies, and Physico-Chemical Testing, performed per OECD/ICH/USP/BP/EP/IP/JP guidelines.
• Medical Device Testing Biocompatibility testing services for medical devices per ISO 10993 and USP standards, covering Cytotoxicity, Skin Sensitization, Eye Irritation, Acute Systemic Toxicity, Implantation, Hemolysis, and Pyrogenicity tests.
• Agro Chemical Testing Comprehensive agrochemical testing services including Acute 6-pack studies, Repeated Dose Toxicity, and Genotoxicity studies per CIBRC, OECD, EPA OCSPP, and other regulatory guidelines for crop protection and chemical registration.
• Alternatives to Animal Testing Alternative testing models aligned with 3Rs principle, including Local Lymph Node Assay (LLNA) using BrdU-ELISA, In vitro Skin and Ocular Irritation Studies, and In vitro Dermal Percutaneous Absorption Studies.
• Histopathology Histopathology services including Tissue Processing, Embedding, Sectioning, Slide Preparation, and Slide Evaluation to support preclinical toxicology studies.
• Clinical Pathology Clinical pathology services including Hematological Parameters, Clinical Chemistry Parameters, Urine Analysis, and ELISA Testing Services for preclinical study support.
• Pharmacology Models In vivo pharmacology efficacy studies including Pain and Inflammatory Models, Neuropathic Pain Models, and Metabolic Disorder Models to support proof-of-concept advancement of NCEs.
• Bioassays Bioassay testing services per Indian, US, European, and British Pharmacopeia, including Heparin Studies, Anti Factor Xa & IIa Activity, Abnormal Toxicity, Rabbit Pyrogen, Estrogenic Activity, and Endotoxin testing.
• Microbiology Microbiology services including Preservative Efficacy Testing, Disinfectant Efficacy Testing, Antibiotic Potency Assay, Endotoxin Testing, Bioburden Testing, and Water Testing.

Quantifiable outcome

• Cost-effective GLP data with rapid turnaround times

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• CH Technologies USAcoreTechnology or IntegrationCH Technologies USA provides specialized nose-only inhalation exposure systems used for inhalation toxicology testing at ERF. The equipment enables precise control of exposure for each individual animal with concentration adjustment capability in the exposure chamber, attached to dedicated AHU for cross-contamination prevention.
• National GLP Compliance Monitoring Authority (NGCMA)coreOthersRegulatory body that certifies GLP compliance for preclinical research organizations in India. ERF holds GLP compliance certification from NGCMA for conducting regulatory toxicology studies.
• AAALAC InternationalcoreOthersAssociation for Assessment and Accreditation of Laboratory Animal Care International provides voluntary accreditation for animal care and use programs. ERF maintains AAALAC accreditation demonstrating commitment to ethical animal welfare standards.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Vimta Labs: Hyderabad-based contract testing and research laboratory offering preclinical, analytical, and bioanalytical services to pharma, agrochemical, and food customers. Most comparable Indian direct peer given overlapping GLP toxicology, analytical, and medical-device testing services from the same city.
• Anthem Biosciences: Bangalore-based contract research organization providing drug discovery, development, and preclinical services including toxicology studies. Comparable Indian preclinical CRO serving similar global sponsor base.
• Sai Life Sciences: India-headquartered CRO providing discovery, CMC, and preclinical research services to global pharma and biotech sponsors. Comparable as an Indian-based preclinical CRO competing for international GLP toxicology contracts.
• Aragen (formerly GVK Biosciences): Indian CRO offering discovery, preclinical, and clinical research services with GLP toxicology capabilities for pharma and agrochemical sponsors. Closely comparable preclinical CRO with overlapping GLP toxicology and chemistry service lines.
• Veeda Lifesciences (Veeda Clinical Research): India-based CRO offering bioanalytical, clinical, and preclinical research services. Comparable Indian CRO with adjacent preclinical/bioanalytical offering to global pharma sponsors.

Broad incumbents

• Jubilant Biosys: India-based CRO offering integrated drug discovery, development, and CDMO services through Jubilant Pharma. Larger, broader incumbent Indian CRO that overlaps with ERF on preclinical toxicology but operates across a wider portfolio.
• WuXi AppTec: China-headquartered global CRO/CDMO providing preclinical toxicology, chemistry, and biologics services. As sponsors diversify away from China concentration toward India, ERF is positioned as an alternative to WuXi for outsourced preclinical work.
• Eurofins Scientific: Global testing services provider with significant pharma/agrochemical laboratory and preclinical testing operations across Europe and Asia. Broad incumbent in analytical and safety testing serving overlapping sponsor segments.
• Syngene International: Publicly listed Indian CRO/CDMO offering discovery, development, and manufacturing services including preclinical toxicology for global pharma. Larger Indian incumbent with broader service portfolio and stronger brand visibility than ERF.
• Charles River Laboratories: Global Tier-1 preclinical CRO and safety assessment specialist with extensive GLP toxicology, inhalation, and analytical service lines. The dominant global incumbent ERF competes against for overflow toxicology work from large sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/edararesearch
• LinkedInlinkedin.com/company/edara-research-foundation

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Edara Research Foundation